Recombinant humanized monoclonal antibody to CD33 for use as a research grade Gemtuzumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
SDS-PAGE for Gemtuzumab Biosimilar - Anti-CD33 Antibody - BSA and Azide free (A338964).
Publishing research using Gemtuzumab Biosimilar - Anti-CD33 Antibody - BSA and Azide free (A338964)? Please let us know so that we can list the citation on this page.
Alternative products to Gemtuzumab Biosimilar - Anti-CD33 Antibody - BSA and Azide free (A338964)
Recombinant human monoclonal antibody to CD33 for use as a research grade Anti-Human CD33 [BI 836858 for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CD33 for use as a research grade Anti-Human CD33 [BI 836858 for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
![Mass Cytometry - Anti-CD33 Antibody [WM53] (A85728)](https://cdn.antibodies.com/image/catalog/85/A85728_1.jpg?profile=product_alternative)
![Flow Cytometry - Anti-CD33 Antibody [WM53] - Low endotoxin, Azide free (A85730)](https://cdn.antibodies.com/image/catalog/85/A85730_1.jpg?profile=product_alternative)
![Immunohistochemistry - Anti-CD33 Antibody [RM398] (A121478) - Antibodies.com](https://cdn.antibodies.com/image/catalog/121/A121484_1.png?profile=product_alternative)
![SDS-PAGE - Anti-CD33 Antibody [SIGLEC3/3600] (A251714) - Antibodies.com](https://cdn.antibodies.com/image/catalog/250/A250658_1.jpg?profile=product_alternative)
![SDS-PAGE - Anti-CD33 Antibody [SIGLEC3/3600] - BSA and Azide free (A250658) - Antibodies.com](https://cdn.antibodies.com/image/catalog/253/A253838_1.jpg?profile=product_alternative)
![ELISA - Anti-CD33 Antibody [DM77] - BSA and Azide free (A318627) - Antibodies.com](https://cdn.antibodies.com/image/catalog/318/A318627_1.jpg?profile=product_alternative)
![SDS-PAGE - Anti-CD33 Antibody [BI 836858] Biosimilar - BSA and Azide free (A339469) - Antibodies.com](https://cdn.antibodies.com/image/catalog/339/A339469_1.jpg?profile=product_alternative)
